search
Back to results

Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy

Primary Purpose

Glaucoma, Cataracts

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
2 Site procedure- Phacoemulsification/IOL and Trabeculectomy
Sponsored by
Lahey Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Glaucoma focused on measuring Glaucoma, Cataracts, Phacoemulsification(IOL), Trabeculectomy

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Meet the current criteria for combined procedure surgery:
  • A visually significant cataract(ie: an opacification of the crystalline lens resulting in a reduction of visual performance affecting daily living
  • Open angle or mixed mechanism glaucoma inadequately controlled on current therapy, or requiring two or more medications for control, or with advanced visual field and optic nerve damage.

Exclusion Criteria:

  • Subjects with normal tension glaucoma(defined as those subjects in whom no IOPs greater than 21 mm Hg[preceding or during therapy]have been recorded)
  • Subjects with uveitis
  • Subjects with neovascular glaucoma
  • Severe conjunctival inflammation or scarring
  • Subjects who have had previous incisional ocular surgery in the same eye
  • No subjects will have second eye operated on within 8 weeks of the first eye

Sites / Locations

  • Lahey Clinic, Inc.

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

1

2

Arm Description

Standard 1 site Procedure using a fornix based incision, performed superiorly

2 Site Combined Procedure

Outcomes

Primary Outcome Measures

Post-Op outcomes of IOP less than or equal to 16mm Hg without additional ocular hypotensive medications

Secondary Outcome Measures

Full Information

First Posted
June 10, 2008
Last Updated
January 21, 2009
Sponsor
Lahey Clinic
search

1. Study Identification

Unique Protocol Identification Number
NCT00695747
Brief Title
Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy
Official Title
Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy
Study Type
Interventional

2. Study Status

Record Verification Date
January 2009
Overall Recruitment Status
Completed
Study Start Date
January 1998 (undefined)
Primary Completion Date
January 2009 (Actual)
Study Completion Date
January 2009 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Lahey Clinic

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to compare the safety & effectiveness of the two types of cataract and glaucoma surgeries. Results from this study may improve the surgical and post surgical management and long term management of patients with these conditions in the future
Detailed Description
The purpose of this study is to determine whether a Two-Site Technique for the Combined Procedure for subjects with coexisting visually significant glaucoma & cataracts will result in an improvement in IOP control in both the immediate and longer term postoperative period as compared with the currently Standard One Site surgical technique for both glaucoma and cataracts. Research and data indicate that the success rate of the glaucoma part of this operation may be improved if the incision for the cataract part of the operation is separated from the drainage hole created for the glaucoma part, the constant drainage through this hole is what lowers the intraocular pressure after surgery. Using the Two-Site Combined procedure the glaucoma incision(drainage hole) will still be created superiorly, under the upper lid. The cataract incision will be moved to the temporal side of the eye ball, away from the drainage hole for the glaucoma.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Glaucoma, Cataracts
Keywords
Glaucoma, Cataracts, Phacoemulsification(IOL), Trabeculectomy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
95 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
No Intervention
Arm Description
Standard 1 site Procedure using a fornix based incision, performed superiorly
Arm Title
2
Arm Type
Experimental
Arm Description
2 Site Combined Procedure
Intervention Type
Procedure
Intervention Name(s)
2 Site procedure- Phacoemulsification/IOL and Trabeculectomy
Other Intervention Name(s)
Coexisting Cataract and glaucoma, Cateract, Glaucoma, Phacoemulsification/IOL, Trabeculectomy
Intervention Description
2 Site Combined Procedure: in which a temporal clear cornea approach would be used for the cataract/IOL part of the procedure, and immediately thereafter the superior limbus would be employed for a limbus-based trabeculectomy
Primary Outcome Measure Information:
Title
Post-Op outcomes of IOP less than or equal to 16mm Hg without additional ocular hypotensive medications
Time Frame
Assessments made at 3 months post op, 3 month intervals for at least 2 years post surgery

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Meet the current criteria for combined procedure surgery: A visually significant cataract(ie: an opacification of the crystalline lens resulting in a reduction of visual performance affecting daily living Open angle or mixed mechanism glaucoma inadequately controlled on current therapy, or requiring two or more medications for control, or with advanced visual field and optic nerve damage. Exclusion Criteria: Subjects with normal tension glaucoma(defined as those subjects in whom no IOPs greater than 21 mm Hg[preceding or during therapy]have been recorded) Subjects with uveitis Subjects with neovascular glaucoma Severe conjunctival inflammation or scarring Subjects who have had previous incisional ocular surgery in the same eye No subjects will have second eye operated on within 8 weeks of the first eye
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paul R. Cotran, M.D.
Organizational Affiliation
Lahey Clinic, Inc.
Official's Role
Principal Investigator
Facility Information:
Facility Name
Lahey Clinic, Inc.
City
Burlington
State/Province
Massachusetts
ZIP/Postal Code
01805
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
2023752
Citation
Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology. 1991 Mar;98(3):317-21. doi: 10.1016/s0161-6420(91)32293-0.
Results Reference
background
PubMed Identifier
8963855
Citation
Shingleton BJ, Jacobson LM, Kuperwaser MC. Comparison of combined cataract and glaucoma surgery using planned extracapsular and phacoemulsification techniques. Ophthalmic Surg Lasers. 1995 Sep-Oct;26(5):414-9.
Results Reference
background
PubMed Identifier
9052620
Citation
Gandolfi SA, Vecchi M. 5-fluorouracil in combined trabeculectomy and clear-cornea phacoemulsification with posterior chamber intraocular lens implantation. A one-year randomized, controlled clinical trial. Ophthalmology. 1997 Feb;104(2):181-6. doi: 10.1016/s0161-6420(97)30336-4.
Results Reference
background
PubMed Identifier
9097805
Citation
Shin DH, Simone PA, Song MS, Reed SY, Juzych MS, Kim C, Hughes BA. Adjunctive subconjunctival mitomycin C in glaucoma triple procedure. Ophthalmology. 1995 Oct;102(10):1550-8. doi: 10.1016/s0161-6420(95)30832-9.
Results Reference
background
PubMed Identifier
7831046
Citation
Joos KM, Bueche MJ, Palmberg PF, Feuer WJ, Grajewski AL. One-year follow-up results of combined mitomycin C trabeculectomy and extracapsular cataract extraction. Ophthalmology. 1995 Jan;102(1):76-83. doi: 10.1016/s0161-6420(95)31050-0.
Results Reference
background
PubMed Identifier
9052621
Citation
Berestka JS, Brown SV. Limbus- versus fornix-based conjunctival flaps in combined phacoemulsification and mitomycin C trabeculectomy surgery. Ophthalmology. 1997 Feb;104(2):187-96. doi: 10.1016/s0161-6420(97)30335-2.
Results Reference
background
PubMed Identifier
9514480
Citation
Scott IU, Greenfield DS, Schiffman J, Nicolela MT, Rueda JC, Tsai JC, Palmberg PF. Outcomes of primary trabeculectomy with the use of adjunctive mitomycin. Arch Ophthalmol. 1998 Mar;116(3):286-91. doi: 10.1001/archopht.116.3.286.
Results Reference
background
Citation
Parrish RK II, Folberg R. Wound healing in glaucoma surgery: In: Ritch R. Shields MB, Krupin T, eds. The Glaucomas 2nd ed. St. Louis: CV Mosby 1989, vol III, chap. 81
Results Reference
background

Learn more about this trial

Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy

We'll reach out to this number within 24 hrs